109401 ⎘
Active agents used in cell culture processes, e.g. differentation; Enzymes Oxidoreductases (EC 1.)
METHOD FOR PROMOTING GENERATION OF MITOCHONDRIA-CONTAINING MICROVESICLE, METHOD FOR GENERATING EXTRACELLULAR VESICLE COMPOSITION, EXTRACELLULAR VESICLE COMPOSITION, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#2PHARMACEUTICAL COMPOSITION FOR TREATING WOUND REPAIR AND PREPARATION METHOD THEREOF
#3SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#4Methods of Epigenetic Analysis
#5CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#6PRODUCTION METHOD FOR PRODUCT
#7IMMUNOSELECTED UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS (UC-MSCs) AND DOWNSTREAM BIOLOGICS
#8Enhanced Transfer of Genetic Instructions to Effector Immune Cells
#9SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#10CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#11METHOD FOR EXPANSION CULTURE OF GAMMA-DELTA T CELL
#12METHODS FOR INCREASING VIRAL TRANSDUCTION OF CELLS
#13COMPOSITIONS AND METHODS FOR ESTABLISHMENT OF BOVINE-INDUCED PLURIPOTENT STEM CELLS
#14SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#15METHOD OF DIFFERENTIATING HUMAN PLURIPOTENT STEM CELLS TO PODOCYTES
#16DIRECT REPROGRAMMING OF CELLS INTO CARDIAC PURKINJE-LIKE CELLS USING A UNIVERSAL SMALLMOLECULE COCKTAIL
#17SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#18MEDIA FOR CULTURING NAIVE HUMAN PLURIPOTENT STEM CELLS
#19Compositions And Methods For Enhancing Immunotherapy
#20Selective oxidation of 5-methylcytosine by TET-family proteins
#21SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#22COMPOSITIONS, DEVICES AND METHODS FOR THE CONTROL IN VITRO OF CHEMICAL MICROAMBIENT IN CELL CULTURES
#23SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#24Chemically Defined Serum Albumin Substitutes
#25METHOD TO REDUCE ONCOGENIC POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FROM AGED DONORS
#26IMMUNOLOGICAL ENHANCEMENT OF STEM CELL ACTIVITY IN TREATMENT OF OVARIAN FAILURE
#27COMPOSITIONS AND METHODS FOR PROMOTING PROLIFERATION IN CARDIOMYOCYTES
#28METHODS FOR OBTAINING MUSCLE DERIVED CELLS
#29INTRACELLULAR DELIVERY OF COMPLEXES
#30METHOD OF PRODUCING TUMOR-REACTIVE T CELL COMPOSITION USING MODULATORY AGENTS
#31Selective oxidation of 5-methylcytosine by TET-family proteins
#32METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS
#33COMPOSITION FOR CULTURING PERIPHERAL BLOOD MONOCYTE-DERIVED REGULATORY T CELL AND REGULATORY T CELL CULTURING METHOD USING SAME
#34Methods of Epigenetic Analysis
#35BIOMARKER FOR PREDICTING ABILITY OF MESENCHYMAL STEM CELLS TO PROLIFERATE AND MIGRATE
#36PRODUCTION OF INSULIN PRODUCING CELLS
#37METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING LACTAM COMPOUNDS
#38Methods of epigenetic analysis
#39METHODS OF EPIGENETIC ANALYSIS
#40PROCESSES FOR ENHANCING YEAST GROWTH AND PRODUCTIVITY
#41Compositions And Methods For Enhancing Immunotherapy
#42REPROGRAMMING FIBROBLASTS TO RETINAL CELLS
#43Methods for obtaining muscle derived cells
#44MEDIUM FOR CULTURING PNEUMOCOCCAL SAMPLES
#45EXTRACELLULAR MATRIX AND ITS USE FOR REGULATING THE DIFFERENTIATION OF MESENCHYMAL STEM CELLS
#46METHOD FOR MATURATION OF RETINAL TISSUE CONTAINING CONTINUOUS EPITHELIUM
#47CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
#48SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#49SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#50METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT
#51SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#52Compositions comprising glucosylated hydroxymethylated bases
#53NEW USE
#54Methods for identifying hydroxylated bases
#55Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures
#56Mammalian cells devoid of lactate dehydrogenase activity
#57Selective oxidation of 5-methylcytosine by TET-family proteins
#58Methods for distinguishing 5-hydroxymethylcytosine from 5-methylcytosine
#59SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#60Method of differentiating human pluripotent stem cells to podocytes
#61SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#62Selective oxidation of 5-methylcytosine by TET-family proteins
#63Methods and compositions for producing fatty alcohols
#64INTRACELLULAR DELIVERY OF COMPLEXES
#65Serum-free medium additive composition containing peroxidasin, and use thereof
#66Detection of 5-hydroxymethylcytosine by glycosylation
#67Labeling hydroxymethylated residues
#68Method to reduce oncogenic potential of induced pluripotent stem cells from aged donors
#69Method for chondrogenic induction
#70Selective oxidation of 5-methylcytosine by TET-family proteins
#71GENERATING INDUCED NEURAL PROGENITOR CELLS FROM BLOOD
#72Selective oxidation of 5-methylcytosine by TET-family proteins
#73Method for producing pluripotent stem cells
#74SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#75SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#76COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE
#77Method for modifying T cell population
#78Production of differentiated enteroendocrine cells and insulin producing cells
#79Media for culturing naive human pluripotent stem cells
#80Selective oxidation of 5-methylcytosine by TET-family proteins
#81Selective oxidation of 5-methylcytosine by TET-family proteins
#82SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#83Selective oxidation of 5-methylcytosine by TET-family proteins
#84Pluripotent cell lines and methods of use thereof
#85Galactose oxidase treatment of dendritic cells to improve their immunogenicity
#86Sophisticated Implant Material
#87Methods and compositions for producing fatty alcohols
#88Method for producing pluripotent stem cells
#89Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
#90Generating hepatocytes
#91Method and composition for preventing stem cell disruption and aggregation
#92Method for inducing differentiation enabling tumorigenesis of IPS cells to be suppressed
#93Endodermal cells from pluripotent cells
#94Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
#95Methods and compositions for producing fatty alcohols
#96Selective oxidation of 5-methylcytosine by TET-family proteins
#97Pluripotent cell lines and methods of use thereof
#98Methods and compositions for producing fatty alcohols
#99STEM CELLS